Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenström macroglobulinemia Journal Article

   

Authors:	Castillo, J. J.; Gustine, J. N.; Meid, K.; Dubeau, T. E.; Xu, L.; Yang, G.; Hunter, Z. R.; Advani, R.; Palomba, L.; Treon, S. P.
Article Title:	Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenström macroglobulinemia
Journal Title:	Haematologica
Volume:	103
Issue:	10
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Date Published:	2018-09-30
Start Page:	e466
End Page:	e468
Language:	English
DOI:	10.3324/haematol.2018.191999
PUBMED:	29773590
PROVIDER:	scopus
PMCID:	PMC6165799
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054371890&doi=10.3324%2fhaematol.2018.191999&partnerID=40&md5=9c716c6907dce7cb0d94e1a061e7c159
Notes:	Letter -- Export Date: 1 November 2018 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/132550